Heartland Group (HGH) M&A announcement summary
Event summary combining transcript, slides, and related documents.
M&A announcement summary
24 Jun, 2026Deal rationale and strategic fit
Merger aims to create a stronger New Zealand challenger bank with enhanced scale, regional focus, and broader product offerings, becoming the seventh largest in the country with $15 billion in assets and a 171% increase in asset base.
Combined entity will leverage both banks' regional strengths, maintain community connections, and retain specialist product focus across New Zealand and Australia.
Strategic drivers include increased scale, diversified product set, realization of synergies, and enhanced shareholder value.
Supports Toi Foundation's philanthropic activities through a diversified investment portfolio.
The merger addresses rising compliance costs and technology investment needs for subscale banks.
Financial terms and conditions
Total consideration is $620 million, including a $50 million pre-completion dividend from TSB, representing 76% of TSB's book value.
Payment structure: $250 million in equity (17.5% shareholding at $1.25/share, 15% premium), $56 million subordinated note, and $264 million vendor loan for two years.
No new ordinary equity required; vendor loan provides capital flexibility.
Transaction costs estimated at $15 million, split between FY2026 and FY2027.
Implied valuation: 0.76x book value, 12x last 12 months NPAT, or 8x including synergies.
Synergies and expected cost savings
Material cost synergies of $34 million per annum expected at full run rate within three years post-completion.
Synergies mainly from reducing shared overheads and duplication, not frontline or product overlap.
Additional upside possible from funding efficiencies, liquidity, and technology leverage, not included in base case.
One-off integration costs expected to be similar in magnitude to annual synergies, at ~$34 million over three years.
Latest events from Heartland Group
- Underlying NPAT fell 4.9% below guidance, but strategic growth and digitalisation drive outlook.HGH
H2 202415 Jun 2026 - Profit dropped on higher impairments, but reverse mortgage growth and NIM expansion continue.HGH
H1 202515 Jun 2026 - FY2025 underlying NPAT met guidance; FY2026 targets $85m+ NPAT and 7%+ ROE.HGH
H2 202515 Jun 2026 - NPAT surged to $48.8m, with NIM and asset quality gains, and FY2026 guidance reaffirmed.HGH
H1 202615 Jun 2026 - Impairment expenses surged amid rising arrears and defaults, with tough conditions expected to continue.HGH
Investor presentation14 May 2026 - FY2025 underlying NPAT set to exceed $45m, with strong growth and improved asset quality.HGH
Investor presentation14 May 2026 - Strategic reset, financial rebound, and digital focus drive growth and efficiency.HGH
AGM 202513 Nov 2025 - Lower profit but strong receivables growth and strategic transformation set the FY2028 path.HGH
AGM 202413 Jun 2025